Of note, antigen-specific regulatory T cells activated by therapeutics antagonizing TNF-α or GM-CSF have been shown play major immune suppressive roles in RA and other autoimmune diseases [48, 49]. The gene discussed is CSF2; the disease is rheumatoid arthritis.